Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Hypertension
Interventions
DIETARY_SUPPLEMENT

BeneFlax®

Daily ingestion of 600 mg SDG/day in 1.6 g SDG-enhanced flax lignan (BeneFlax®) with walking training or flexibility training

BEHAVIORAL

Walking training

30-60 minutes walking training, 5 days/week.

BEHAVIORAL

Flexibility training

5 days/week; e.g. stretching training at home

DIETARY_SUPPLEMENT

Placebo (Whey Protein)

0.6 g/day (an amount equal in volume to BeneFlax®) with walking training or flexibility training

BEHAVIORAL

Dash Eating Plan

Dietary Approaches to Stop Hypertension (DASH), a balanced eating plan - all participants in all treatment arms will be encouraged to adopt a DASH eating plan.

Trial Locations (1)

S7N 5E5

College of Pharmacy, University of Saskatchewan, Saskatoon

All Listed Sponsors
lead

University of Saskatchewan

OTHER

NCT02391779 - Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension | Biotech Hunter | Biotech Hunter